Βαλβιδοπάθειες. Από ηις τειροσργικές ζηις διαδερμικές θεραπείες

Size: px
Start display at page:

Download "Βαλβιδοπάθειες. Από ηις τειροσργικές ζηις διαδερμικές θεραπείες"

Transcription

1 Βαλβιδοπάθειες. Από ηις τειροσργικές ζηις διαδερμικές θεραπείες Ιωάννης Δ. Κανονίδης Καθηγηηής Καρδιολογίας Α.Π.Θ. Γιεσθσνηης Β Καρδιολογικής Κλινικής Α.Π.Θ. Γενικό Νοζοκομείο Θεζζαλονίκης «Ιπποκράηειο»

2 Cardiac Surgery

3 Any surgeon attempting an operation of the heart would lose the respect of his colleagues Theodor Billroth (1883)

4 In 1923 Dr. Elliott Cutler of the Peter Bent Brigham Hospital performed the world s first successful heart valve surgery - a mitral valve repair. The patient was a 12- year-old girl with rheumatic mitral stenosis.

5 In 1925 Henry Souttar operated successfully on a young woman with mitral stenosis. He made an opening in the appendage of the left atrium and inserted a finger into this chamber in order to palpate and explore the damaged mitral valve. The patient survived for several years Souttar s physician colleagues at that time decided the procedure was not justified and he could not continue.

6 Cardiac surgery changed significantly after World War II In 1948 four surgeons working independently of each other carried out successful operations for mitral stenosis due to rheumatic fever. Horace Smithy ( ) of Charlotte, revived an operation due to Dr Dwight Harken of the Peter Bent Brigham Hospital using a punch to remove a portion of the mitral valve. Charles Bailey ( ) at the Hahnemann Hospital, Philadelphia, Dwight Harken in Boston Russell Brock at Guy s Hospital All adopted Souttar s method. All these men started work independently of each other, within a few months. This time Souttar s technique was widely adopted although there were modifications.

7

8 First Aortic Valve Replacement Murray, in Toronto considered replacing a diseased valve with a valve taken from a donor animal. Encouraged by results of his experiments with dogs he implanted a valve harvested from a human cadaver into descending thoracic aorta of a 22 Yr. man who had severe AR. This man was a manual worker & was asymptomatic when seen 6 Yrs later First Aortic Valve Repair May Dr. Lillehei repaired an Aortic Valve in a female patient on the heart-lung machine

9 Mechanical prostheses Mitral Valve First implant was done in early 1960 s in USA Aorta First Aortic prosthesis implant performed on a patient in March 1960 in Florida, USA Double Valve Surgery First Double Valve Implant was performed in November 1961 in Pittsburgh, Pennsylvania, USA

10 Πρώηη Γενιά Τεχνηηών Καρδιακών Βαλβίδων Star-Edwards: Κλωβού και ζθαίρας First implanted by Starr and Harken in 1960.

11

12 Miles "Lowell" Edwards

13 Ball-and-Cage Valves Opening and closure of the ball-valve

14 Δεύηερη Γενιά Τεχνηηών Καρδιακών Βαλβίδων Star-Edwards: Lillehei-Kaster: 1967 Carpentier-Edwards: 1968 Βιοπρόζθεζη Hancock I: 1969 Βιοπρόζθεζη Jonescn-Shiley: Bjork-Shiley: St. Jude Medical: Βιοπρόζθεζη 1969 BSST 1980 BSCC 70

15 Τρίηη Γενιά Τεχνηηών Καρδιακών Βαλβίδων St. Jude Medical: 1977 Medtronic-Hall: 1977 M-H-1980 Bjork-Shiley Monostrut: 1982 (απεζύρθη) Omniscience: 1978 Duromedics: 1981 Carpentier-Edwards: 1981 Βιοπρόζθεζη Hancock ΙI: 1982 Βιοπρόζθεζη Carbomedics Inc.: 1986 Omnicarbon: 1984

16 Types of Prosthetic Heart Valves I Caged-ball Starr-Edwards Braunwald-Cutter Smeloff-Cromie

17 Types of Prosthetic Heart Valves II Tilting-disk Björk-Shiley Björk-Shiley convexoconcave Medtronic-Hall Lillihei-Kaster Omniscience Sorin

18 Bjork-Shiley Bjork-Shiley Bjork-Shiley in the Mitral position

19 Types of Prosthetic Heart Valves III Bileaflet St. Jude Medical Carbomedics Duromedics

20 St. Jude valve St. Jude valve in the mitral position.

21 Flow Dynamics

22 Mechanical valves Designs and flow patterns of different types of mechanical valves

23 Types of prosthetic valves and thrombogenicity Type of valve Model Thrombogenicity Mechanical Caged ball Starr-Edwards Single tilting disc Bjork-Shiley, Medtronic Hall Bileaflet Bioprosthetic Heterografts St Jude Medical, Sorin Bicarbon, Carbomedics + + Carpentier-Edwards, Tissue Med (Aspire), Hancock II + to + + Homografts +

24 Ideal valve Good hemodynamic Quiet Require no anticoagulation Last for life time Cheap Easy to implant

25 Mechanical Valves Extremely durable with overall survival rates of 94% at 10 years Primary structural abnormalities are rare Most malfunctions are secondary to perivalvular leak and thrombosis Chronic anticoagulation required in all With adequate anticoagulation, rate of thrombosis is 0.6% to 1.8% per patient-year for bileaflet valves

26 Homografts first aortic valve homograft was used in the descending thoracic aorta for aortic regurgitation In 1962 Alfred Gunning & co-workers in Oxford worked out a reliable method for aortic homograft harvest & preparation. This allowed Ross to perform the first landmark sub-coronary homograft implantation in This success was soon followed by Barrat-Boyce in New Zealand, Mattias Paneth & Mark O Brien at Brompton hospital. Alfred Gunning These were the people who adopted & pioneered homograft aortic replacement at a time when most surgeons preferred the durability & simplicity of Starr Edward valve insertion with a single row of sutures. The homograft insertion was technically more demanding in an era when myocardial preservation was primitive.

27 DEVELOPMENT OF PORCINE BIOPROSTHESIS In 1964 after their succes with homografts, Gunning & Duran diverted their attention to preservation of heteregenous valves. In the same year they performed first human stent mounted porcine valve implantation In 1965 Duran & Carpentier presented their experience of mercurochrome preserved frame mounted heterografts. This was soon followed by reports by Mark O Brien about his experience with formalin preserved pig & calf aortic heterografts. However, long term results were poor because of primitive preservation methods

28 Marion Ionescu ( Leeds) In 1966 Ionescu developed a stent for mounting aortic heterograts. It had Titanium support, 3 legs covered with dacron velour & dacron felt ring was used as a sewing ring. The porcine aortic valve was sutured within the frame.

29 Carpentier next produced a stent made of stainless steel coated with Teflon to minimise thromboembolism & he used mercurial salt for tissue preservation. This stent is the precursor of stent used in modern Carpentier- Edward valve Within 5 yrs of use of stented valves it was realised that stent mounting caused excessive stress on the biological tissue which resulted in accelerated degeneration. This setback caused practice of stent mounting to disappear.

30 1968 -Preservation of tissues with formaldehyde or mercurochrome was proving disappointing, this problem was soon resolved by Carpentier who employed gluteraldehyde preservation for the first time. The chemical treatment of tissues prevents collagen denaturation & reduces antegenicity of foreign tissues

31

32 AUTOGRAFTS ROSS OPERATION In 1967 Ross performed the first pulmonary autograft operation for aortic valve replacement. Initially autogenous pulmonary valve was used as a sub- coronary implant & later as a full aortic root replacement. Ross anticipated that autologus pulmonary valve will remain viable & maintain potential for growth in children. Experience have shown this to be true. Whilst Ross persisted with his operation others were reluctant to perform a complex double root replacement for isolated aortic disease which otherwise could be treated with very low morbidity & mortality with a stented valve. is to be true.

33 DEVELOPMENTS IN REPLACEMENT OF MITRAL VALVE Ross attempted to replace mitral valve with a mitral homograft. Though early post-operative hemodynamics were excellent, most patients sustained rupture of chordae tendeniae within a few months of operation. In addition proper placement of papillary muscles inside LV required considerable judgment & skills. Because of these reasons MV homografts replacement has never regained wide spread acceptance.

34 STENTLESS VALVES In 1988 Tyrone David re-explored the use of stentless gluteraldehyde fixed aortic xenograft. Hemodynamic evaluation showed very small gradients & minimal regurgitation in early implants.

35 Stentless Valves Medtronic Freestyle St. Jude Toronto SPV

36 Bioprosthetic Bioprosthetic Valve types: heterografts, homografts advantage: short term anticoagulation limitation: structural failure leaflet calcification & tissue degeneration leading to valvular regurgitation rate of porcine valve degeneration 26% (aortic), 39% (mitral) in 10 yrs

37 Biologic (Tissue) Stented Porcine xenograft Pericardial xenograft Stented bioprostheses Primary mechanical failure at 10 years is 15-20% Preferred in patients over age 70 Subject to progressive calcific degeneration & failure after 6-8 years

38 Types of Bioprosthetic Valves I Porcine (stented) Hancock I Hancock II Hancock MO (modified orifice) Carpentier-Edwards C/E Duraflex Medtronic Intact Bioimplant

39 Types of Bioprosthetic Valves II Pericardial Ionescu-Shiley Carpentier-Edwards pericardial Mitroflow

40 Biological Valves Stentless Porcine xenograft Pericardial xenograft Stentless bioprostheses Absence of stent & sewing cuff allow implantation of larger valve for given annular size->greater EOA Uses the patient s own aortic root as the stent, absorbing the stress induced during the cardiac cycle

41 Biologic Valves Continued Homografts Harvested from cadaveric human hearts Advantages: resistance to infection, lack of need for anticoagulation, excellent hemodynamic profile (in smaller aortic root sizes) More difficult surgical procedure limits its use Autograft Ross Procedure

42

43

44 Mitral valve repair CARPENTIER CLASSIFICATION

45 Τεχνικές Διόρθωσης Μιτροειδούς Βαλβίδας Δακτύλιος α) Tοποθέηηζη δακηςλίος (Carpentier, Duran, Cosgrove) β) Δακηςλιοπλαζηική Γλωχίνες Μεπική εκηομή και ζςππαθή ή μόνο πλαζηική μεηάθεζη σοπδών επί πήξεωρ αςηών, ζμίκπςνζη σοπδών ή θηλοειδών μςών επί επιμηκύνζεωρ αςηών. Κινηηοποίηζη γλωσίνων καηόπιν εκηομήρ σοπδών ηηρ βάζηρ ή δεςηεπεςόνηων. Yποβαλβιδικός μηχανισμός Κινηηοποίηζη ηος ςποβαλβιδικού μησανιζμού καηόπιν διαίπεζηρ ηων θηλοειδών μςών μέσπι ηη βάζη αςηών, απομάκπςνζη αζβεζηίος.

46

47 Aortic valve repair Aortic valve repair is a surgical procedure used to correct some aortic valve disorders as an alternative to aortic valve replacement. Aortic valve repair is performed less often and is more technically difficult than mitral valve repair. There are two surgical techniques of aortic-valve repair: The Reimplantation-Technique (David-Procedure) The Remodeling-Technique (Yacoub-Procedure)

48 Minimally invasive Cardiac Surgery Endoscopic or robotic heart surgery. Hugo Vanerman (Belgium). In minimally invasive valve surgery, long-handled tools are inserted into the chest through four or more small incisions. While watching a video monitor, the surgeon manipulates the tools and conducts the surgery. In some cases, robotic arms may be used to manipulate the tools for the surgeon. Only some hospitals can offer minimally invasive valve surgery. Cardiac surgeons are not unanimous about the relative merits of sternotomy versus the minimally invasive approach. The minimally invasive approach can produce a less prominent scar, is beneficial for very obese patients, and may allow the patient to return to their normal activity sooner than a sternotomy.

49 VALVES AND INTERVENTIONAL CARDIOLOGY

50 Balloon Valvuloplasty Valvuloplasty is the widening of a stenotic valve using a balloon catheter. Types include: Aortic valvuloplasty in repair of a stenotic aortic valve Mitral valvuloplasty in the correction of an uncomplicated mitral valve Pulmonary valvuloplasty

51 Percutaneous mitral valvuloplasty 1.Single large balloon 2.Double balloon 3.Multi Track System (P. Bonhoeffer) 4.Innoue balloon

52 Inn-oue balloon Valvuloplasty of the Mitral Valve." The balloon is sub-divided into 3 segments and is dilated in 3 stages. 1st the distal portion (lying in the left ventricle) is inflated and pulled against the valve cusps. 2nd the proximal portion is dilated, in order to fix the centre segment at the valve orifice. Finally, the central section is inflated, This should take no longer than 30 seconds since full inflation obstructs the valve and causes congestion, leading to circulatory arrest and flash pulmonary edema.

53 Aortic balloon valvuloplasty 1.Anterograde approach (transeptal) 2.Retrograde approach

54 Percutaneous valve replacement 1.Bonhoeffer: pulmonary (2000) 2.Al. Cribier: aortic (2002)

55

56 The SAPIEN valve Lifesciences. made by Edwards The CoreValve system made by Medtronic

57 Percutaneous aortic valve replacement Implants the valve using a catheter, without open heart surgery. It is used in more than 50 countries in patients who are at extreme or high risk to undergo open heart surgery In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aortic-valve replacement had similar rates of survival at 1 year, although there were important differences in risks associated with the procedure. [2] The transcatheter procedure was associated with a higher risk of stroke than the surgical replacement (5.5% vs. 2.4% after 30 days; 8.3% vs. 4.3% after 1 year). [3]

58 Mitral Valve Clip

59 Feldman (2005)

60 What about the futur?

61 Thank you!

62 Prosthetic Valves are classified as tissue or mechanical Tissue: Actual valve or one made of biologic tissue from an animal (bioprosthesis or heterograft) or human (homograft or autograft) source Mechanical Made of nonbiologic material (pyrolitic carbon, polymeric silicone substances, or titanium) Blood flow characteristics, hemodynamics, durability, and thromboembolic tendency vary depending on the type and size of the prosthesis and characteristics of the patient

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, 2016 1:50 2:10 PM 20 min 1 M U H A M E D S A R I Ć, M D, P H D D i r e c t

More information

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Heart Valve Replacements From the Old to. the New

Heart Valve Replacements From the Old to. the New Heart Valve Replacements From the Old to Timothy P. Obarski, DO, FACC, FACP Director of Echocardiography Assistant professor of Medicine Division of Cardiology The Ohio State Wexner Medical Center Columbus,

More information

Echocardiographic Evaluation of Mitral Valve Prostheses

Echocardiographic Evaluation of Mitral Valve Prostheses Echocardiographic Evaluation of Mitral Valve Prostheses Dennis A. Tighe, M.D., FACC, FACP, FASE Cardiovascular Medicine University of Massachusetts Medical School Worcester, MA www.asecho.org 1 Nishimura

More information

Surgical Treatment for Valvular Heart Disease

Surgical Treatment for Valvular Heart Disease Chapter 34 Surgical Treatment for Valvular Heart Disease Peter J. K. Starek Competency of the atrioventricular valves allows blood to enter the ventricles, where pressure is generated. When adequate systolic

More information

Iatrogenic pathology of the heart:

Iatrogenic pathology of the heart: Iatrogenic pathology of the heart: Complications of mitral valve plasty and replacement Patrick Bruneval D pt of Pathology Hôpital Européen Georges Pompidou Enterprise Interest None Mitral valve surgery

More information

CoreValve in a Degenerative Surgical Valve

CoreValve in a Degenerative Surgical Valve CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,

More information

2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD

2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD 2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD David L Saint M.D. Tallahassee Memorial Hospital Southern Medical Group Division of Cardiothoracic

More information

Heart Valves: Before and after surgery

Heart Valves: Before and after surgery Heart Valves: Before and after surgery Tim Sutton, Consultant Cardiologist Middlemore Hospital, Auckland Auckland Heart Group Indications for intervention in Valvular disease To prevent sudden death and

More information

Late failure of transcatheter heart valves: An open question

Late failure of transcatheter heart valves: An open question Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement

More information

RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES

RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES e-issn:2322-0139 RESEARCH AND REVIEWS: JOURNAL OF PHARMACOLOGY AND TOXICOLOGICAL STUDIES Comparative Evaluation of Safety Outcomes of Different Prosthetic Valves in Indian Subjects. Kama Raval 1 *, Reena

More information

Adult Cardiac Surgery

Adult Cardiac Surgery Adult Cardiac Surgery Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac Surgery: Ischemic Heart Disease

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information

Spotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France

Spotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Spotlight on valvular heart disease guidelines. Prosthetic heart valves. Bernard Iung Bichat Hospital, Paris Diderot University Paris, France Faculty disclosure First name - last name I disclose the following

More information

Hardware in the Chest - From VADs to Valves

Hardware in the Chest - From VADs to Valves Hardware in the Chest - From VADs to Valves Cristina Fuss, MD Purpose Recognize the device Indication and function Cristina Fuss, MD Department of Diagnostic Radiology FROM VADS TO VALVES Implanting technique

More information

PROSTHETIC. V PROSTHETIC.V

PROSTHETIC. V PROSTHETIC.V PROSTHETIC. V PROSTHETIC.V VALVE TYPE The valve types now implanted include: 1-bileaflet and tilting disc mechanical valves, 2-stented porcine and pericardial xenografts, 3-stentless porcine xenografts,

More information

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,

Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham

More information

Cardiac Valve/Structural Therapies

Cardiac Valve/Structural Therapies Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,

More information

25 different brand names >44 different models Sizes mm

25 different brand names >44 different models Sizes mm Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single

More information

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim 42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease B K Singh, MD, FACC Disclosures: None 1 CARDIAC CYCLE S2 S2=A2P2 S1=M1T1 S4 S1 S3 2 JVP Carotid S1 Slitting of S2 S3 S4 Ejection click Opening snap Dynamic Auscultation What is the

More information

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,

More information

Percutaneous Therapy for Calcific Mitral Valve Disease

Percutaneous Therapy for Calcific Mitral Valve Disease 31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive

More information

Management of Difficult Aortic Root, Old and New solutions

Management of Difficult Aortic Root, Old and New solutions Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult

More information

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D

More information

Prosthetic valve dysfunction: stenosis or regurgitation

Prosthetic valve dysfunction: stenosis or regurgitation Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in

More information

PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement

PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT Tissue Valve for Aortic and Mitral Valve Replacement ARE MEDTRONIC SURGICAL TISSUE HEART VALVES RIGHT FOR YOU? Medtronic surgical heart valves are for

More information

Aortic stenosis and regurgitation

Aortic stenosis and regurgitation 1 Aortic stenosis and regurgitation valvuloplasty and replacement Mitral regurgitation and stenosis valvuloplasty and repair/replacement 2 ASD PFO VSD PDA occlusion Left atrial appendage occlusion for

More information

Transapical Transcatheter Aortic Valve Implantation in the Presence of a Mitral Prosthesis

Transapical Transcatheter Aortic Valve Implantation in the Presence of a Mitral Prosthesis Journal of the American College of Cardiology Vol. 58, No. 7, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.04.023

More information

Biological or mechanical valve prosthesis?

Biological or mechanical valve prosthesis? XXIX Giornate Cardiologiche Torinesi ADVANCES IN CARDIAC ARRHYTHMIAS AND GREAT INNOVATIONS IN CARDIOLOGY Turin, October 27-28, 2017 Centro Congressi Unione Industriale WHAT HAS CHANGED IN CARDIAC SURGERY?

More information

I will not discuss off label use or investigational use in my presentation.

I will not discuss off label use or investigational use in my presentation. I will not discuss off label use or investigational use in my presentation. Surgical valves Design and Durability Testing Potential Concerns Real Practice 1952-1962 1963-1966 1967-1969 1969-1977 1977-1984

More information

Stainless Steel. Cobalt-chromium

Stainless Steel. Cobalt-chromium Sapien is better than Corevalve! Raj R. Makkar, MD Associate Director, Cedars-Sinai Heart Institute Associate Professor, UCLA School of Medicine, Los Angeles Eberhard Grube: Pioneer in the field of TAVR

More information

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for

More information

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Update on Oral Anticoagulation for Mechanical Heart Valves

Update on Oral Anticoagulation for Mechanical Heart Valves Update on Oral Anticoagulation for Mechanical Heart Valves Douglas C. Anderson, Pharm.D., D.Ph. Professor and Chair Dept. of Pharmacy Practice Cedarville University School of Pharmacy OHIO SOCIETY OF HEALTH-SYSTEM

More information

14 Valvular Stenosis

14 Valvular Stenosis 14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a

More information

UNDERSTANDING YOUR HEART VALVE. Mosaic Tissue Valve

UNDERSTANDING YOUR HEART VALVE. Mosaic Tissue Valve UNDERSTANDING YOUR HEART VALVE Mosaic Tissue Valve A Message to You from the Employees at Medtronic, Inc. We understand that having heart valve replacement surgery is an important change in your life.

More information

A Practical Approach to Prosthetic Valves

A Practical Approach to Prosthetic Valves A Practical Approach to Prosthetic Valves Bonita Anderson DMU (Cardiac), MApplSc (Med Ultrasound), ACS, AMS, FASE https://doi.org/10.1161/circulationaha.108.778886 Disclosures None 1 Know the Product Know

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

The St. Jude Medical Biocor Bioprosthesis

The St. Jude Medical Biocor Bioprosthesis The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year

More information

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This

More information

A brief history of valvular surgery

A brief history of valvular surgery Cardiac surgery Valvular heart disease University of Pecs, Medical Faculty Heart Institute A brief history of valvular surgery 1925. Souttar closed mitral commissurotomy 1960. McGoon plasty for mitral

More information

PPM: How to fit a big valve in a small heart

PPM: How to fit a big valve in a small heart PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat

More information

Replacement Heart Valve Product Description (Stented Tissue) Models Reference

Replacement Heart Valve Product Description (Stented Tissue) Models Reference Dear Imaging Center: This letter is in response to your inquiry concerning the safety of performing magnetic resonance (MR) procedures in patients who have been implanted with Edwards Lifesciences LLC

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Mechanical heart valves and Anticoagulation. Dr. Alkesh ZALA Basic Physician trainee, Dept. of Cardiology, John Hunter hospital.

Mechanical heart valves and Anticoagulation. Dr. Alkesh ZALA Basic Physician trainee, Dept. of Cardiology, John Hunter hospital. Mechanical heart valves and Anticoagulation Dr. Alkesh ZALA Basic Physician trainee, Dept. of Cardiology, John Hunter hospital. Today s discussion: Case review The currently Available and most commonly

More information

Transcatheter Mitral Valve Replacement How Close Are We?

Transcatheter Mitral Valve Replacement How Close Are We? Transcatheter Mitral Valve Replacement How Close Are We? Gregory Pavlides, MD, PhD, FACC, FESC Professor of Medicine Miscia Chair of Interventional Cardiology Director, Cardiac Catheterization Laboratories,

More information

Replacement Heart Valve Product Description (Stented Tissue) Models Reference

Replacement Heart Valve Product Description (Stented Tissue) Models Reference Dear Imaging Center: This letter is in response to your inquiry concerning the safety of performing magnetic resonance (MR) procedures in patients who have been implanted with Edwards Lifesciences LLC

More information

Percutaneous Valve Interventions. Percutaneous Valve Interventions

Percutaneous Valve Interventions. Percutaneous Valve Interventions Percutaneous Valve Interventions Stanton J. Rowe President, Percutaneous Valve Interventions Edwards is Best Positioned to Capitalize on Percutaneous Valve Opportunities #1 global valve replacement and

More information

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,

Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic, transplantation and Vascular Surgery Hannover Medical School, Germany

More information

Echocardiographic Evaluation of Aortic Valve Prosthesis

Echocardiographic Evaluation of Aortic Valve Prosthesis Echocardiographic Evaluation of Aortic Valve Prosthesis Amr E Abbas, MD, FACC, FASE, FSCAI, FSVM, RPVI Co-Director, Echocardiography, Director, Interventional Cardiology Research, Beaumont Health System

More information

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates

Worldwide rheumatic fever is the most common cause of valve disease. In industrialized areas, valvular disease of old age predominates Michael Sumners DO Epidemiology Worldwide rheumatic fever is the most common cause of valve disease In industrialized areas, valvular disease of old age predominates Calcific aortic stenosis Functional

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis

More information

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses Review Article Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses Dale J. Murdoch, John G. Webb Centre for Heart Valve Innovation, St. Paul s Hospital, Vancouver, Canada Contributions:

More information

Excellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP

Excellence in heart and lung care. Royal Brompton Hospital, Sydney Street, London SW3 6NP The Surgical Management of the Bicuspid Aortic Valve in Children Professor D.F Shore Royal Brompton & Harefield NHS Trust Excellence in heart and lung care Royal Brompton Hospital, Sydney Street, London

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

Transcatheter Pulmonary Valve Replacement Update on progress and outcomes

Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Transcatheter Pulmonary Valve Replacement Update on progress and outcomes Barry Love, MD Director, Congenital Cardiac Catheterization Laboratory Mount Sinai Medical Center New York, New York Transcatheter

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up

CONTRIBUTION. Aortic valve replacement in young patients: long-term follow-up CONTRIBUTION Aortic valve replacement in young patients: long-term follow-up DOUGLAS S. MOODIE, MD; USAMA HANHAN, MD; RICHARD STERBA, MD; DANIEL J. MURPHY, Jr, MD; ELIOT R. ROSENKRANZ, MD; ANDREA M. KOVACS,

More information

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University. Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD Director Cath Labs, Washington Hospital Center. ProfessorofMedicine (Cardiology), Georgetown University. Conflict of Interest Proctor

More information

Recommended Monographs and Guidelines on Heart Valve Surgery

Recommended Monographs and Guidelines on Heart Valve Surgery Recommended Monographs and Guidelines on Heart Valve Surgery 403 Recommended Monographs and Guidelines Recommended Monographs and Guidelines on Heart Valve Surgery 404 Monographs on Heart Valve Surgery

More information

Repeated mitral valve replacement in a patient with extensive annular calcification

Repeated mitral valve replacement in a patient with extensive annular calcification CASE REPORT Open Access Repeated mitral valve replacement in a patient with extensive annular calcification Tadashi Kitamura 1,2*, Sachito Fukuda 1, Takahiro Sawada 1, Sumio Miura 1, Ikutaro Kigawa 1,3

More information

Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa

Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa Charles Hufnagel developed and successfully implanted the first prosthetic cardiac valve in the descending thoracic aorta

More information

10 ο ΣΥΝΕΔΡΙΟ ΕΠΕΜΒΑΤΙΚΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ ΚΑΙ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓΙΑΣ Σεπτεμβρίου 2017 Electra Palace Θεσσαλονικη

10 ο ΣΥΝΕΔΡΙΟ ΕΠΕΜΒΑΤΙΚΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ ΚΑΙ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓΙΑΣ Σεπτεμβρίου 2017 Electra Palace Θεσσαλονικη 10 ο ΣΥΝΕΔΡΙΟ ΕΠΕΜΒΑΤΙΚΗΣ ΚΑΡΔΙΟΛΟΓΙΑΣ ΚΑΙ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓΙΑΣ 14-16 Σεπτεμβρίου 2017 Electra Palace Θεσσαλονικη Ηχωκαρδιογραφία στην ένδειξη-προετοιμασία, διενέργεια, παρακολούθηση ασθενών που υποβάλλονται

More information

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,

More information

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation ESC Congress 2010 28 Aug 2010-01 Sep 2010 Stockholm - Sweden Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation Gian Paolo Ussia, MD Director of Interventional

More information

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia. Decision process for Management of any valve Timing Feasibility

More information

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Update from PARTNER EU and SOURCE Registries T. Lefèvre Disclosure Statement Cardiologist Interventional cardiologist 1 st PABV in

More information

ESC/EACTS Guidelines for the Management of Valvular Heart Disease

ESC/EACTS Guidelines for the Management of Valvular Heart Disease ES/EATS Guidelines for the Management of Valvular Heart Disease European Journal of ardio-thoracic Surgery 2012 - Why do we need new guidelines on the management of valvular disease? New evidence has been

More information

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD. My Choice For Percutaneous Mitral Valve Replacement Jose Luis Navia, MD. Disclosure Edwards Lifescienses St. Jude Medical MAQUET NaviGate Consultant, Investigator Consultant, Investigator Consultant, Investigator

More information

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment

Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background

More information

TAVI and Valve Replacement Thromboprophylaxis. Warren Prokopiw Pharmacy Resident

TAVI and Valve Replacement Thromboprophylaxis. Warren Prokopiw Pharmacy Resident TAVI and Valve Replacement Thromboprophylaxis Warren Prokopiw Pharmacy Resident 2011-2012 Case Mr MW 76 yo Admitted 14 May for worsening CHF PMH: Aortic Stenosis, CVD (CABG x4 1980, PCI x3 stent 2008)

More information

The stentless bioprosthesis has many salient features that

The stentless bioprosthesis has many salient features that Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive

More information

How to Avoid Prosthesis-Patient Mismatch

How to Avoid Prosthesis-Patient Mismatch How to Avoid Prosthesis-Patient Mismatch Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE, FESC Canada Research Chair in Valvular Heart Diseases INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE DE QUÉBEC

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Cardiac catheterisation in AS

Cardiac catheterisation in AS AORTIC STENOSIS MANAGEMENT OF VALVULAR AORTIC STENOSIS Dr Badri Paudel Third most common cardiovascular disease Most prevalent valvular heart disease in the world Commonest acquired valvular lesion with

More information

Conflict of Interests

Conflict of Interests Introduction to Interventional Echocardiography Roberto M Lang, MD Tomtec Conflict of Interests Research Grants Philips Medical Imaging Research Grants Speakers bureau Advisory bureau 1 Structural Heart

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/28521 holds various files of this Leiden University dissertation Author: Katsanos, Spyridon Title: Outcomes of transcatheter aortic valve implantation Issue

More information

Choice of Prosthetic Heart Valve in Adults

Choice of Prosthetic Heart Valve in Adults Journal of the American College of Cardiology Vol. 55, No. 22, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.10.085

More information

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,

More information

DISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE.

DISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE. Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? G. Burkhard Mackensen, MD, PhD, FASE Professor & Chief, Division of Cardiothoracic Anesthesia, Department of Anesthesiology

More information

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio

More information

BY LUCAS W. HENN, MD; RAJ R. MAKKAR, MD, FACC, FSCAI; AND GREGORY P. FONTANA, MD, FACS, FACC

BY LUCAS W. HENN, MD; RAJ R. MAKKAR, MD, FACC, FSCAI; AND GREGORY P. FONTANA, MD, FACS, FACC Valve-in-Valve TAVI for Degenerated Surgical Prostheses Transcatheter aortic valve implantation is being used in novel ways to treat degenerated surgical prostheses with promising results. BY LUCAS W.

More information

Next Generation Therapies: Aortic, Mitral and Beyond

Next Generation Therapies: Aortic, Mitral and Beyond Next Generation Therapies: Aortic, Mitral and Beyond Scott M Lilly, MD PhD Medical (Interventional) Director, Structural Heart Program Heart Summit, Lima OH August 26 th, 2017 Next Generation Therapies:

More information

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat

More information

Posterior leaflet prolapse is the most common lesion seen

Posterior leaflet prolapse is the most common lesion seen Techniques for Repairing Posterior Leaflet Prolapse of the Mitral Valve Robin Varghese, MD, MS, and David H. Adams, MD Posterior leaflet prolapse is the most common lesion seen in degenerative mitral valve

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

Valvular Heart Disease

Valvular Heart Disease GP Update Refresher 18 th January 2018 Valvular Heart Disease Dr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

P have been used for mitral and aortic valve replacement

P have been used for mitral and aortic valve replacement A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,

More information

Indications and Late Results of Aortic Valve Repair

Indications and Late Results of Aortic Valve Repair Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the

More information

A new era in cardiac valve surgery has begun...

A new era in cardiac valve surgery has begun... THE CENTER FOR VALVE SURGERY A new era in cardiac valve surgery has begun... Good Help to Those in Need Rawn Salenger, MD, FACS, Director, The Center for Valve Surgery Edward F. Lundy, MD, PhD, Chief of

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years

Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years Surgery for Acquired Cardiovascular Disease Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years W. R. Eric Jamieson, MD, Lawrence H. Burr, MD, Robert T. Miyagishima,

More information